Blogs
on February 19, 2024
The latest report by IMARC Group, titled “ Bioprocess Bags Market Report by Type (2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags and Accessories), Workflow (Upstream Process, Downstream Process, Process Development, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, CMOs and CROs, Academic and Research Institutes, and Others), and Region 2024-2032, offers a comprehensive analysis of the industry, which comprises insights on the global bioprocess bags market trends. The global market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2032, exhibiting a growth rate (CAGR) of 15.39% during 2024-2032.
Factors Affecting the Growth of the Bioprocess Bags Industry:
- Technological Advancements Driving Innovation:
The growth of the bioprocess bags industry is significantly influenced by technological advancements that drive innovation in manufacturing processes, materials, and product design. As bioprocessing continues to evolve, there is a growing demand for more efficient, cost-effective, and scalable solutions for the production of biologics, vaccines, and other biopharmaceuticals. Manufacturers are investing in research and development to enhance the performance and functionality of bioprocess bags, incorporating advanced materials such as single-use plastics, polymers, and films with superior properties such as durability, flexibility, and compatibility with various bioprocessing applications. Moreover, technological advancements in manufacturing processes, such as blow molding and extrusion, enable the production of bioprocess bags with precise dimensions, improved sealing integrity, and customized configurations to meet the specific requirements of biopharmaceutical manufacturers.
- Increasing Adoption of Single-Use Technologies:
The bioprocess bags industry is experiencing significant growth due to the increasing adoption of single-use technologies (SUTs) by biopharmaceutical manufacturers worldwide. Single-use bioprocessing systems offer several advantages over traditional stainless-steel equipment, including reduced risk of cross-contamination, shorter setup times, lower capital investment, and increased flexibility in manufacturing operations. Bioprocess bags are integral components of single-use bioprocessing systems, serving as containers for cell culture media, buffers, and other process fluids during upstream and downstream bioprocessing operations. The rising demand for biologics, monoclonal antibodies, gene therapies, and personalized medicines has propelled the adoption of single-use bioprocessing technologies, driving the market growth for bioprocess bags. Biopharmaceutical companies are increasingly leveraging single-use bioprocessing solutions to expedite process development, scale up production, and accelerate time-to-market for innovative therapies.
- Expanding Biopharmaceutical Pipeline and Outsourcing Trends:
The expanding pipeline of biopharmaceutical products, coupled with the growing trend of outsourcing biomanufacturing activities, is fueling the demand for bioprocess bags globally. Biopharmaceutical companies are increasingly focusing on developing innovative therapies targeting various therapeutic areas such as oncology, autoimmune diseases, infectious diseases, and rare disorders, driving the need for efficient and scalable bioprocessing solutions. Bioprocess bags play a crucial role in supporting the production of biologics, vaccines, biosimilars, and cell-based therapies, providing a reliable and cost-effective solution for biomanufacturing. Moreover, the outsourcing of bioprocessing activities to contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) is contributing to the growth of the bioprocess bags market.
Competitive Landscape with Key Player:
- CellBios Healthcare & Lifesciences Pvt. Ltd.
- Charter Medical Ltd. (Solesis Medical Technologies Inc.)
- Compagnie de Saint-Gobain S.A.
- Danaher Corporation
- Entegris Inc
- FlexBiosys Inc. (Repligen Corporation)
- ILC Dover LP
- Indutrade AB
- PROAnalytics LLC
- Sartorius AG
- Thermo Fisher Scientific Inc.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bioprocess-bags-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Type Insights:
- 2D Bioprocess Bags
- 3D Bioprocess Bags
- Other Bags and Accessories
2D bioprocess bags represented the largest segment due to their widespread use in various biopharmaceutical manufacturing processes and their compatibility with a wide range of bioreactors and mixing systems.
Workflow Insights:
- Upstream Process
- Downstream Process
- Process Development
- Others
The upstream process represented the largest segment because it encompasses critical stages such as cell culture, fermentation, and cell expansion, which require the use of bioprocess bags for media storage, cell growth, and nutrient supplementation.
End User Insights:
- Pharmaceutical and Biopharmaceutical Companies
- CMOs and CROs
- Academic and Research Institutes
- Others
Pharmaceutical & biopharmaceutical companies represented the largest segment owing to their extensive utilization of bioprocess bags in the production of biologics, vaccines, monoclonal antibodies, and other biopharmaceutical products.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America's dominance in the bioprocess bags market is attributed to the presence of a well-established biopharmaceutical industry, high investment in research and development, robust regulatory framework, and increasing adoption of single-use technologies in bioprocessing operations.
Global Bioprocess Bags Market Trends:
The global market is primarily driven by increasing investments in research and development, advancements in biotechnology, and a growing demand for biologic-based therapies. Additionally, the rising disposable nature of bioprocess bags eliminates the need for costly cleaning procedures, resulting in overall cost-efficiency and accelerated production timelines, further propelling market growth.
Moreover, the rapid globalization of biopharmaceutical manufacturing operations, particularly in emerging markets, is driving the adoption of single-use technologies such as bioprocess bags, which is further contributing to market expansion. Furthermore, the increasing outsourcing of bioproduction services to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) is fueling the demand for this product in the market.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Posted in: Business